PTK2 and ovarian carcinoma: The similar phenomenon was observed in human prostate tumor cells (12, 38).We also tested the efficacy of FAK PROTAC using orthotopic OC mouse models and showed marked activity in vivo to inhibit ovarian tumor growth and metastasis, thus potentially transform the clinical ovarian cancer therapy.